oral+semaglutide+approval FDA-Approved Oral Semaglutide: The First GLP-1 Pill Semaglutide, the First Oral GLP-1

Thin needles reduce skin trauma and are easier to use for regular weekly injections

Second mechanism GIP

Retatrutide is an investigational once-weekly injectable triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, increase energy expenditure, and improve metabolic control

Energy gets better if B12 is supported

Diarrhea is one of the most commonly reported side effects associated with using Retatrutide

Quick Answer: Wegovy and Wellbutrin can be taken together as there is no absolute contraindication, though concurrent use requires careful clinical assessment and monitoring by a qualified healthcare professional